10-27100385-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014915.3(ANKRD26):​c.-59G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0884 in 1,596,866 control chromosomes in the GnomAD database, including 7,963 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.080 ( 702 hom., cov: 34)
Exomes 𝑓: 0.089 ( 7261 hom. )

Consequence

ANKRD26
NM_014915.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.943

Publications

15 publications found
Variant links:
Genes affected
ANKRD26 (HGNC:29186): (ankyrin repeat domain containing 26) This gene encodes a protein containing N-terminal ankyrin repeats which function in protein-protein interactions. Mutations in this gene are associated with autosomal dominant thrombocytopenia-2. Pseudogenes of this gene are found on chromosome 7, 10, 13 and 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
ANKRD26 Gene-Disease associations (from GenCC):
  • thrombocytopenia 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal thrombocytopenia with normal platelets
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary thrombocytopenia and hematologic cancer predisposition syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 10-27100385-C-T is Benign according to our data. Variant chr10-27100385-C-T is described in ClinVar as Benign. ClinVar VariationId is 260454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.27 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKRD26NM_014915.3 linkc.-59G>A 5_prime_UTR_variant Exon 1 of 34 ENST00000376087.5 NP_055730.2 Q9UPS8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKRD26ENST00000376087.5 linkc.-59G>A 5_prime_UTR_variant Exon 1 of 34 5 NM_014915.3 ENSP00000365255.4 Q9UPS8-1

Frequencies

GnomAD3 genomes
AF:
0.0796
AC:
12113
AN:
152170
Hom.:
690
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0180
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.0881
Gnomad EAS
AF:
0.281
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.127
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0814
Gnomad OTH
AF:
0.0903
GnomAD4 exome
AF:
0.0894
AC:
129089
AN:
1444576
Hom.:
7261
Cov.:
34
AF XY:
0.0907
AC XY:
65235
AN XY:
719006
show subpopulations
African (AFR)
AF:
0.0142
AC:
471
AN:
33218
American (AMR)
AF:
0.107
AC:
4735
AN:
44064
Ashkenazi Jewish (ASJ)
AF:
0.0899
AC:
2340
AN:
26016
East Asian (EAS)
AF:
0.276
AC:
10929
AN:
39656
South Asian (SAS)
AF:
0.143
AC:
12178
AN:
85314
European-Finnish (FIN)
AF:
0.111
AC:
4613
AN:
41610
Middle Eastern (MID)
AF:
0.0975
AC:
402
AN:
4122
European-Non Finnish (NFE)
AF:
0.0788
AC:
87560
AN:
1110622
Other (OTH)
AF:
0.0978
AC:
5861
AN:
59954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
6971
13942
20913
27884
34855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3424
6848
10272
13696
17120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0797
AC:
12139
AN:
152290
Hom.:
702
Cov.:
34
AF XY:
0.0864
AC XY:
6435
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0181
AC:
753
AN:
41576
American (AMR)
AF:
0.111
AC:
1704
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0881
AC:
306
AN:
3472
East Asian (EAS)
AF:
0.282
AC:
1454
AN:
5162
South Asian (SAS)
AF:
0.155
AC:
749
AN:
4824
European-Finnish (FIN)
AF:
0.127
AC:
1352
AN:
10610
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0814
AC:
5537
AN:
68022
Other (OTH)
AF:
0.100
AC:
212
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
569
1137
1706
2274
2843
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0790
Hom.:
715
Bravo
AF:
0.0739
Asia WGS
AF:
0.237
AC:
824
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Thrombocytopenia 2 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
7.8
DANN
Benign
0.81
PhyloP100
-0.94
PromoterAI
-0.088
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=182/118
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3737056; hg19: chr10-27389314; API